Subscribe to RSS
Download PDF
DOI: 10.1055/s-0044-1800862
Radiofrequency Ablation for Recurrent Papillary Thyroid Carcinoma at the Central Compartment Node: A Case Report
Funding None.
Abstract
Papillary thyroid carcinoma is the most common thyroid cancer with a good prognosis. However, local recurrence or cervical lymph node metastasis is frequent. Reoperation is a standard treatment but may be challenging due to the formation of fibrosis, cervical anatomy distortion, and the small size of recurrent lesions. Radiofrequency ablation (RFA) is a minimally invasive modality for recurrent thyroid cancer in high-risk patients or those who refuse surgery. Here, we describe the case of a 41-year-old woman who underwent total thyroidectomy with central neck dissection because of papillary thyroid carcinoma. Follow-up ultrasonography 14 months after the second surgery revealed two abnormal lymph nodes in the right neck at level VI. She underwent RFA of the lymph nodes. Eighteen months after RFA, the metastasis lymph nodes disappeared completely.
Keywords
papillary thyroid cancer - radiofrequency ablation - recurrent thyroid cancer - lymph node - thyroid cancer metastasesPublication History
Article published online:
11 December 2024
© 2024. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Mauri G, Hegedüs L, Bandula S. et al. European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 Clinical Practice Guideline for the Use of Minimally Invasive Treatments in Malignant Thyroid Lesions. Eur Thyroid J 2021; 10 (03) 185-197
- 2 Ywata de Carvalho A, Kohler HF, Gomes CC, Vartanian JG, Kowalski LP. Predictive factors for recurrence of papillary thyroid carcinoma: analysis of 4,085 patients. Acta Otorhinolaryngol Ital 2021; 41 (03) 236-242
- 3 Teng D, Ding L, Wang Y, Liu C, Xia Y, Wang H. Safety and efficiency of ultrasound-guided low power microwave ablation in the treatment of cervical metastatic lymph node from papillary thyroid carcinoma: a mean of 32 months follow-up study. Endocrine 2018; 62 (03) 648-654
- 4 Mauri G, Cova L, Ierace T. et al. Treatment of metastatic lymph nodes in the neck from papillary thyroid carcinoma with percutaneous laser ablation. Cardiovasc Intervent Radiol 2016; 39 (07) 1023-1030
- 5 Kim BM, Kim MJ, Kim EK, Park SI, Park CS, Chung WY. Controlling recurrent papillary thyroid carcinoma in the neck by ultrasonography-guided percutaneous ethanol injection. Eur Radiol 2008; 18 (04) 835-842
- 6 Lee SJ, Jung SL, Kim BS. et al. Radiofrequency ablation to treat loco-regional recurrence of well-differentiated thyroid carcinoma. Korean J Radiol 2014; 15 (06) 817-826
- 7 Dupuy DE, Monchik JM, Decrea C, Pisharodi L. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery 2001; 130 (06) 971-977
- 8 Yang Z, Yan L, Xiao J. et al. Long-term results of radiofrequency ablation for locally recurrent papillary thyroid carcinoma. Int J Hyperthermia 2023; 40 (01) 2191912
- 9 Chen WC, Chou CK, Chang YH. et al. Efficacy of radiofrequency ablation for metastatic papillary thyroid cancer with and without initial biochemical complete status. Front Endocrinol (Lausanne) 2022; 13: 933931
- 10 Ahmad S, Aljammal J, Orozco I. et al. Radiofrequency ablation of cervical thyroid cancer metastases-experience of endocrinology practices in the United States. J Endocr Soc 2023; 7 (07) bvad066
- 11 Baek JH, Kim YS, Sung JY, Choi H, Lee JH. Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation. AJR Am J Roentgenol 2011; 197 (02) W331-6
- 12 Ahmad S, Asad AS, Khan F, Maqbool A, Irfan Z, Aljammal J. Recurrent papillary thyroid carcinoma of central compartment node treated with radiofrequency ablation. Video Endocrinol TM 2023; 10 (04) 59-61
- 13 Choi Y, Jung SL, Bae JS. et al. Comparison of efficacy and complications between radiofrequency ablation and repeat surgery in the treatment of locally recurrent thyroid cancers: a single-center propensity score matching study. Int J Hyperthermia 2019; 36 (01) 359-367
- 14 Yang Z, Zhang M, Yan L. et al. Value of radiofrequency ablation for treating locally recurrent thyroid cancer: a systematic review and meta-analysis for 2-year follow-up. Endocrine 2024; 85 (03) 1066-1074
- 15 Kim JH, Yoo WS, Park YJ. et al. Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm. Radiology 2015; 276 (03) 909-918
- 16 Chung SR, Suh CH, Baek JH, Park HS, Choi YJ, Lee JH. Safety of radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: a systematic review and meta-analysis. Int J Hyperthermia 2017; 33 (08) 920-930
- 17 Ha EJ, Baek JH, Che Y. et al. Radiofrequency ablation of benign thyroid nodules: recommendations from the Asian Conference on Tumor Ablation Task Force. Ultrasonography 2021; 40 (01) 75-82